Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali

被引:65
作者
Djimde, Abdoulaye A. [1 ]
Fofana, Bakary [1 ]
Sagara, Issaka [1 ]
Sidibe, Bakary [1 ]
Toure, Sekou [1 ]
Dembele, Demba [1 ]
Dama, Souleymane [1 ]
Ouologuem, Dinkorma [1 ]
Dicko, Alassane [1 ]
Doumbo, Ogobara K. [1 ]
机构
[1] Univ Bamako, Fac Med Pharm & Odonto Stomatol, Dept Epidemiol Parasit Dis, Malaria Res & Training Ctr, Bamako, Mali
关键词
D O I
10.4269/ajtmh.2008.78.455
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We conducted a randomized single-blinded trial comparing the efficacy and safety of artesunate (AS) + amodiaquine (AQ, 3 days) versus AS (3 days) + sulfadoxine-pyrimethamine (SP, single dose) versus AS monotherapy (5 days) in Southern Mali. Uncomplicated malaria cases were followed for 28 days. Molecular markers of drug resistance were determined. After identification of recrudescences by genotyping, both artemisinin-based combination therapies (ACTS) reached nearly 100% efficacy at Day 14 and Day 28 versus 98.3% and 96.5% for AS, respectively (P > 0.05). AS + SP significantly selected DHFR and DHPS; mutations associated with sulfadoxine and pyrimethamine resistance (P < 0.001), and AS + AQ equally selected PfCRT and PfMDR1 point mutations associated with chloroquine and AQ resistance (P < 0.001). No significant adverse event attributable to any of the study drugs was found. The ACTS were efficacious and safe, but the selection of markers for resistance to the partner drugs raises concerns over their lifespan in areas of intense malaria transmission.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 41 条
[1]  
Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8
[2]   Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children:: a randomised, multicentre trial [J].
Adjuik, M ;
Agnamey, P ;
Babiker, A ;
Borrmann, S ;
Brasseur, P ;
Cisse, M ;
Cobelens, F ;
Diallo, S ;
Faucher, JF ;
Garner, P ;
Gikunda, S ;
Kremsner, PG ;
Krishna, S ;
Lell, B ;
Loolpapit, M ;
Matsiegui, PB ;
Missinou, MA ;
Mwanza, J ;
Ntoumi, F ;
Olliaro, P ;
Osimbo, P ;
Rezbach, P ;
Some, E ;
Taylor, WRJ .
LANCET, 2002, 359 (9315) :1365-1372
[3]  
[Anonymous], 1996, ASS THER EFF ANT DRU
[4]   Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya [J].
Bousema, JT ;
Gouagna, LC ;
Meutstege, AM ;
Okech, BE ;
Akim, NIJ ;
Githure, JI ;
Beier, JC ;
Sauerwein, RW .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2003, 8 (05) :427-430
[5]  
Bouvier P, 1997, AM J EPIDEMIOL, V145, P850, DOI 10.1093/oxfordjournals.aje.a009179
[6]   A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-Saharan Africa [J].
Coleman, PG ;
Morel, C ;
Shillcutt, S ;
Goodman, C ;
Mills, AJ .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 71 (02) :196-204
[7]   DYNAMICS OF MALARIA PARASITEMIA ASSOCIATED WITH FEBRILE ILLNESS IN CHILDREN FROM A RURAL AREA OF MADANG, PAPUA-NEW-GUINEA [J].
COX, MJ ;
KUM, DE ;
TAVUL, L ;
NARARA, A ;
RAIKO, A ;
BAISOR, M ;
ALPERS, MP ;
MEDLEY, GF ;
DAY, KP .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 (02) :191-197
[8]   Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali [J].
de Radigues, Xavier ;
Diallo, Kandian I. ;
Diallo, Mouctar ;
Ngwakum, Paul Akisa ;
Maiga, Hamma ;
Djimde, Abdoulaye ;
Sacko, Massambou ;
Doumbo, Ogobara ;
Guthmann, Jean-Paul .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2006, 100 (11) :1013-1018
[9]   Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali [J].
Diourté, Y ;
Djimdé, A ;
Doumbo, OK ;
Sagara, I ;
Coulibaly, Y ;
Dicko, A ;
Diallo, M ;
Diakité, M ;
Cortese, JF ;
Plowe, CV .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (03) :475-478
[10]  
Djimdé A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403